Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 010310/0485 | |
| Pages: | 3 |
| | Recorded: | 10/19/1999 | | |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
5
|
|
Patent #:
|
|
Issue Dt:
|
01/07/1992
|
Application #:
|
07320139
|
Filing Dt:
|
03/07/1989
|
Title:
|
MODIFIED EGLIN PROTEINS
|
|
|
Patent #:
|
|
Issue Dt:
|
01/29/2002
|
Application #:
|
07707265
|
Filing Dt:
|
05/24/1991
|
Title:
|
A PROCESS FOR PREPARING RECOMBINANT ELGIN PROTEASE INHIBITOR
|
|
|
Patent #:
|
|
Issue Dt:
|
01/19/1993
|
Application #:
|
07776547
|
Filing Dt:
|
10/11/1991
|
Title:
|
GENES ENCODING EGLIN C MUTANTS
|
|
|
Patent #:
|
|
Issue Dt:
|
01/19/1999
|
Application #:
|
08369829
|
Filing Dt:
|
01/06/1995
|
Title:
|
ANTISTASIN-TYPE SERINE PROTEASE INHIBITORS
|
|
|
Patent #:
|
|
Issue Dt:
|
10/26/1999
|
Application #:
|
08586676
|
Filing Dt:
|
01/25/1996
|
Title:
|
TRYPTASE INHIBITOR
|
|
Assignee
|
|
|
TALSTRASSE 82 |
CH-4001 ZURICH, SWITZERLAND |
|
Correspondence name and address
|
|
NOVARTIS CORPORATION
|
|
MICHAEL W. GLYNN
|
|
564 MORRIS AVENUE
|
|
PATENT AND TRADEMARK DEPT.
|
|
SUMMIT, NJ 07901-1027
|
Search Results as of:
09/24/2024 04:43 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|